BlackRock’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3K | Sell |
7,006
-15,295
| -69% | -$26.8K | ﹤0.01% | 5127 |
|
|
2025
Q1 | $30.3K | Sell |
22,301
-303
| -1% | -$412 | ﹤0.01% | 4973 |
|
|
2024
Q4 | $85.8K | Buy |
22,604
+439
| +2% | +$1.67K | ﹤0.01% | 4765 |
|
|
2024
Q3 | $59.8K | Buy |
22,165
+8,413
| +61% | +$22.7K | ﹤0.01% | 4721 |
|
|
2024
Q2 | $42.6K | Buy |
13,752
+7,413
| +117% | +$23K | ﹤0.01% | 4846 |
|
|
2024
Q1 | $28.8K | Buy |
6,339
+1,075
| +20% | +$4.88K | ﹤0.01% | 4919 |
|
|
2023
Q4 | $36.2K | Hold |
5,264
| – | – | ﹤0.01% | 4940 |
|
|
2023
Q3 | $33.2K | Hold |
5,264
| – | – | ﹤0.01% | 5007 |
|
|
2023
Q2 | $43.7K | Sell |
5,264
-5,737
| -52% | -$47.6K | ﹤0.01% | 4998 |
|
|
2023
Q1 | $48.4K | Buy |
11,001
+186
| +2% | +$818 | ﹤0.01% | 5041 |
|
|
2022
Q4 | $63.8K | Sell |
10,815
-1,757
| -14% | -$10.4K | ﹤0.01% | 5079 |
|
|
2022
Q3 | $88K | Sell |
12,572
-173
| -1% | -$1.21K | ﹤0.01% | 5127 |
|
|
2022
Q2 | $185K | Buy |
12,745
+5,493
| +76% | +$79.7K | ﹤0.01% | 4966 |
|
|
2022
Q1 | $273K | Buy |
7,252
+91
| +1% | +$3.43K | ﹤0.01% | 4948 |
|
|
2021
Q4 | $559K | Buy |
+7,161
| New | +$559K | ﹤0.01% | 4766 |
|